Skip to main content

Table 1 Demographic and clinical characteristics in patients with NVAF n = 593

From: Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

VariablesClassificationN (%)
GenderFemale281 (47.4)
PaymentSelf-paying130 (21.9)
Age, years< 6076 (12.8)
 60~69157 (26.5)
 70~79205 (34.6)
 ≥80155 (26.1)
EducationPrimary school or below316 (53.3)
 Junior high school145 (24.5)
 Senior high school and above132 (22.2)
AF typeParoxysmal381 (64.3)
 Persistent172 (29.0)
 Permanent40 (6.7)
Duration, years< 5335 (56.3)
Severity of symptomAsymptomatic61 (10.3)
 Mild334 (56.3)
 Moderate169 (28.5)
 Severe29 (4.9)
StrokeYes66 (11.1)
Concomitant disease
 HypertensionYes359 (60.5)
 Diabetes mellitusYes118 (19.9)
 Coronary heart diseaseYes138 (23.2)
 Heart failureYes94 (15.8)
 Vascular diseaseYes27 (4.6)
 HyperlipidemiaYes38 (6.4)
 Impaired renal/liver functionYes29 (4.9)
 HAS-BLED, score<  3531 (89.5)
 CHA2DS2-VASC, scoreMale: 0~2; female: 0~1161 (27.2)
 Male ≥3; female ≥2432 (72.8)
  1. Abbreviations: AF Atrial fibrillation, CHA2DS2-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years,sex category (female), HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, NVAF Non-valvular atrial fibrillation, TIA Transient ischemic attack